Fig. 1From: A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cellsMIL-38-CD3 BiTE Construct. a Schematic of MIL-38-CD3 BiTE (b) Western blot detection of purified MIL-38-CD3 BiTE (Lane 1: L = supernatant loaded onto purification column, Lane 2: FT = flow through and Lane 3: E = column eluate)Back to article page